Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Gains from Investment Securities: 2011-2024

Historic Gains from Investment Securities for Cryo Cell International (CCEL) over the last 14 years, with FY2024 value amounting to $113600.0.

  • Cryo Cell International's Gains from Investment Securities changed 0.0% to $103000.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $2.8 million, marking a year-over-year increase of 440242.62%. This contributed to the annual value of $113600.0 for FY2024, which is 9376.1% down from last year.
  • Cryo Cell International's Gains from Investment Securities amounted to $113600.0 in FY2024, which was down 9376.1% from $1.8 million recorded in FY2023.
  • Over the past 5 years, Cryo Cell International's Gains from Investment Securities peaked at $3.5 million during FY2021, and registered a low of -$1.9 million during FY2020.
  • Its 5-year average for Gains from Investment Securities is $1.0 million, with a median of $1.6 million in 2022.
  • Per our database at Business Quant, Cryo Cell International's Gains from Investment Securities crashed by 16116.0% in 2020 and then soared by 28209.01% in 2021.
  • Over the past 5 years, Cryo Cell International's Gains from Investment Securities (Annual) stood at -$1.9 million in 2020, then soared by 282.09% to $3.5 million in 2021, then crashed by 55.49% to $1.6 million in 2022, then rose by 15.78% to $1.8 million in 2023, then plummeted by 93.76% to $113600.0 in 2024.
  • Its Gains from Investment Securities was $113600.0 in FY2024, compared to $1.8 million in FY2023 and $1.6 million in FY2022.